SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5hk2'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JB0_B_PQNB2002_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	5 / 11	PHE A 58 SER A 130 ALA A 46 LEU A 61 ALA A 57	None SO4 A 304 (-4.1A) None None None	1.47A	1jb0B-5hk2A: undetectable	1jb0B-5hk2A: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	5 / 12	ALA A 46 LEU A 61 PHE A 58 ALA A 57 GLY A 131	None	1.05A	2ve3A-5hk2A: undetectable	2ve3A-5hk2A: 20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PCQ_B_PQNB842_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	5 / 11	PHE A 58 SER A 130 ALA A 46 LEU A 61 ALA A 57	None SO4 A 304 (-4.1A) None None None	1.47A	3pcqB-5hk2A: undetectable	3pcqB-5hk2A: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R0L_D_ACTD127_0 (PHOSPHOLIPASE A2 CB)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	4 / 5	PHE A 37 ILE A 42 GLY A 174 HIS A 97	None	1.31A	3r0lD-5hk2A: undetectable	3r0lD-5hk2A: 18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W9N_C_CCSC1548_0 (ENOYL-[ACYL-CARRIER- PROTEIN] REDUCTASE)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	3 / 3	ALA A 92 TRP A 81 VAL A 82	None	0.24A	4w9nC-5hk2A: undetectable	4w9nC-5hk2A: 22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HPU_C_IPHC101_0 (INSULIN, CHAIN A INSULIN, CHAIN B)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	4 / 6	CYH A 94 LEU A 79 HIS A 97 LEU A 96	None	1.03A	5hpuC-5hk2A: undetectable 5hpuD-5hk2A: undetectable	5hpuC-5hk2A: 7.02 5hpuD-5hk2A: 12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IEN_A_VDYA201_1 (CDL2.2)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	5 / 12	LEU A 203 MET A 170 ILE A 124 THR A 189 ALA A 86	None None 61V A 301 ( 4.7A) None None	1.30A	5ienA-5hk2A: undetectable	5ienA-5hk2A: 19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JWA_A_ACTA609_0 (NADH DEHYDROGENASE, PUTATIVE)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	3 / 3	VAL A 162 SER A 117 TRP A 89	None 61V A 301 (-2.9A) None	0.97A	5jwaA-5hk2A: undetectable	5jwaA-5hk2A: 18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OY0_B_PQNB1844_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	5 / 10	PHE A 58 SER A 130 ALA A 46 LEU A 61 ALA A 57	None SO4 A 304 (-4.1A) None None None	1.48A	5oy0b-5hk2A: undetectable	5oy0b-5hk2A: 15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1B_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 3)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	3 / 3	ARG A 66 PHE A 58 LEU A 79	None	0.86A	5x1bC-5hk2A: undetectable	5x1bC-5hk2A: 19.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_A_GMJA301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	6 / 12	ILE A 124 PHE A 133 VAL A 152 HIS A 154 THR A 160 ALA A 86	61V A 301 ( 4.7A) None None 61V A 301 ( 4.1A) None None	1.00A	6djzA-5hk2A: 34.9	6djzA-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_A_GMJA301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	9 / 12	MET A 93 LEU A 105 PHE A 133 VAL A 152 HIS A 154 THR A 160 VAL A 162 LEU A 186 ALA A 185	61V A 301 (-3.4A) None None None 61V A 301 ( 4.1A) None None None 61V A 301 ( 4.2A)	1.49A	6djzA-5hk2A: 34.9	6djzA-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_A_GMJA301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	12 / 12	MET A 93 TYR A 103 LEU A 105 ILE A 124 PHE A 133 VAL A 152 HIS A 154 THR A 160 VAL A 162 LEU A 182 ALA A 185 TYR A 206	61V A 301 (-3.4A) 61V A 301 ( 4.3A) None 61V A 301 ( 4.7A) None None 61V A 301 ( 4.1A) None None None 61V A 301 ( 4.2A) 61V A 301 (-3.6A)	0.58A	6djzA-5hk2A: 34.9	6djzA-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_A_GMJA301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	6 / 12	PHE A 133 VAL A 152 HIS A 154 THR A 160 LEU A 186 ALA A 86	None None 61V A 301 ( 4.1A) None None None	0.95A	6djzA-5hk2A: 34.9	6djzA-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_A_GMJA301_1 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	6 / 6	SER A 117 TYR A 120 ASP A 126 GLN A 135 GLU A 172 THR A 181	61V A 301 (-2.9A) None 61V A 301 (-3.2A) None 61V A 301 (-2.9A) 61V A 301 ( 4.7A)	0.56A	6djzA-5hk2A: 34.9	6djzA-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_B_GMJB301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	7 / 12	SER A 117 PHE A 133 HIS A 154 THR A 160 VAL A 162 TRP A 164 LEU A 186	61V A 301 (-2.9A) None 61V A 301 ( 4.1A) None None None None	1.03A	6djzB-5hk2A: 35.1	6djzB-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_B_GMJB301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	12 / 12	TRP A 89 TYR A 103 LEU A 105 SER A 117 ILE A 124 PHE A 133 HIS A 154 THR A 160 VAL A 162 TRP A 164 THR A 181 LEU A 182	None 61V A 301 ( 4.3A) None 61V A 301 (-2.9A) 61V A 301 ( 4.7A) None 61V A 301 ( 4.1A) None None None 61V A 301 ( 4.7A) None	0.63A	6djzB-5hk2A: 35.1	6djzB-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_B_GMJB301_1 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	4 / 6	ASP A 126 VAL A 152 GLU A 172 ALA A 86	61V A 301 (-3.2A) None 61V A 301 (-2.9A) None	1.20A	6djzB-5hk2A: 35.1	6djzB-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_B_GMJB301_1 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	6 / 6	TYR A 120 ASP A 126 GLN A 135 VAL A 152 GLU A 172 ALA A 185	None 61V A 301 (-3.2A) None None 61V A 301 (-2.9A) 61V A 301 ( 4.2A)	0.36A	6djzB-5hk2A: 35.1	6djzB-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_C_GMJC301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	9 / 12	ALA A 98 SER A 117 PHE A 133 VAL A 152 HIS A 154 VAL A 162 THR A 181 LEU A 182 TYR A 206	61V A 301 ( 4.8A) 61V A 301 (-2.9A) None None 61V A 301 ( 4.1A) None 61V A 301 ( 4.7A) None 61V A 301 (-3.6A)	0.84A	6djzC-5hk2A: 34.1	6djzC-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_C_GMJC301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	11 / 12	MET A 93 ALA A 98 LEU A 105 SER A 117 PHE A 133 VAL A 152 HIS A 154 VAL A 162 THR A 181 ALA A 185 TYR A 206	61V A 301 (-3.4A) 61V A 301 ( 4.8A) None 61V A 301 (-2.9A) None None 61V A 301 ( 4.1A) None 61V A 301 ( 4.7A) 61V A 301 ( 4.2A) 61V A 301 (-3.6A)	0.51A	6djzC-5hk2A: 34.1	6djzC-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_C_GMJC301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	9 / 12	MET A 93 ALA A 98 LEU A 105 SER A 117 VAL A 153 HIS A 154 THR A 181 ALA A 185 TYR A 206	61V A 301 (-3.4A) 61V A 301 ( 4.8A) None 61V A 301 (-2.9A) None 61V A 301 ( 4.1A) 61V A 301 ( 4.7A) 61V A 301 ( 4.2A) 61V A 301 (-3.6A)	1.45A	6djzC-5hk2A: 34.1	6djzC-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DJZ_C_GMJC301_1 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	6 / 6	TRP A 89 LEU A 95 TYR A 120 ASP A 126 GLN A 135 GLU A 172	None None None 61V A 301 (-3.2A) None 61V A 301 (-2.9A)	0.34A	6djzC-5hk2A: 34.1	6djzC-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DK1_A_GM4A301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	9 / 11	VAL A 84 ALA A 86 TRP A 89 MET A 93 TYR A 103 LEU A 105 TRP A 164 GLU A 172 ALA A 185	61V A 301 (-4.5A) None None 61V A 301 (-3.4A) 61V A 301 ( 4.3A) None None 61V A 301 (-2.9A) 61V A 301 ( 4.2A)	0.74A	6dk1A-5hk2A: 34.1	6dk1A-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DK1_A_GM4A301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	10 / 11	VAL A 84 ALA A 86 TRP A 89 MET A 93 TYR A 103 LEU A 105 TYR A 120 ASP A 126 TRP A 164 GLU A 172	61V A 301 (-4.5A) None None 61V A 301 (-3.4A) 61V A 301 ( 4.3A) None None 61V A 301 (-3.2A) None 61V A 301 (-2.9A)	0.64A	6dk1A-5hk2A: 34.1	6dk1A-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DK1_A_GM4A301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	5 / 11	VAL A 84 LEU A 105 ASP A 126 GLU A 172 ALA A 86	61V A 301 (-4.5A) None 61V A 301 (-3.2A) 61V A 301 (-2.9A) None	1.49A	6dk1A-5hk2A: 34.1	6dk1A-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DK1_B_GM4B301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	11 / 11	VAL A 84 ALA A 86 TRP A 89 TYR A 103 LEU A 105 TYR A 120 ASP A 126 TRP A 164 GLU A 172 ALA A 185 LEU A 186	61V A 301 (-4.5A) None None 61V A 301 ( 4.3A) None None 61V A 301 (-3.2A) None 61V A 301 (-2.9A) 61V A 301 ( 4.2A) None	0.54A	6dk1B-5hk2A: 33.6	6dk1B-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DK1_C_GM4C301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	11 / 11	VAL A 84 ALA A 86 TRP A 89 TYR A 103 LEU A 105 TYR A 120 ASP A 126 TRP A 164 GLU A 172 THR A 181 ALA A 185	61V A 301 (-4.5A) None None 61V A 301 ( 4.3A) None None 61V A 301 (-3.2A) None 61V A 301 (-2.9A) 61V A 301 ( 4.7A) 61V A 301 ( 4.2A)	0.70A	6dk1C-5hk2A: 33.7	6dk1C-5hk2A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6DK1_C_GM4C301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	5hk2	SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1 (Homo sapiens)	5 / 11	VAL A 84 LEU A 105 ASP A 126 GLU A 172 ALA A 86	61V A 301 (-4.5A) None 61V A 301 (-3.2A) 61V A 301 (-2.9A) None	1.44A	6dk1C-5hk2A: 33.7	6dk1C-5hk2A: 100.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1JB0_B_PQNB2002_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",5,"PHE A  58;SER A 130;ALA A  46;LEU A  61;ALA A  57","None;SO4 A 304 (-4.1A);None;None;None","1.47A","1jb0B-5hk2A:undetectable","1jb0B-5hk2A:15.09"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",5,"ALA A  46;LEU A  61;PHE A  58;ALA A  57;GLY A 131","None","1.05A","2ve3A-5hk2A:undetectable","2ve3A-5hk2A:20.05"],["3PCQ_B_PQNB842_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",5,"PHE A  58;SER A 130;ALA A  46;LEU A  61;ALA A  57","None;SO4 A 304 (-4.1A);None;None;None","1.47A","3pcqB-5hk2A:undetectable","3pcqB-5hk2A:15.09"],["3R0L_D_ACTD127_0","PHOSPHOLIPASE A2 CB","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",4,"PHE A  37;ILE A  42;GLY A 174;HIS A  97","None","1.31A","3r0lD-5hk2A:undetectable","3r0lD-5hk2A:18.92"],["4W9N_C_CCSC1548_0","ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",3,"ALA A  92;TRP A  81;VAL A  82","None","0.24A","4w9nC-5hk2A:undetectable","4w9nC-5hk2A:22.02"],["5HPU_C_IPHC101_0","INSULIN, CHAIN A;INSULIN, CHAIN B","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",4,"CYH A  94;LEU A  79;HIS A  97;LEU A  96","None","1.03A","5hpuC-5hk2A:undetectable;5hpuD-5hk2A:undetectable","5hpuC-5hk2A:7.02;5hpuD-5hk2A:12.15"],["5IEN_A_VDYA201_1","CDL2.2","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",5,"LEU A 203;MET A 170;ILE A 124;THR A 189;ALA A  86","None;None;61V A 301 ( 4.7A);None;None","1.30A","5ienA-5hk2A:undetectable","5ienA-5hk2A:19.56"],["5JWA_A_ACTA609_0","NADH DEHYDROGENASE, PUTATIVE","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",3,"VAL A 162;SER A 117;TRP A  89","None;61V A 301 (-2.9A);None","0.97A","5jwaA-5hk2A:undetectable","5jwaA-5hk2A:18.78"],["5OY0_B_PQNB1844_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A2","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",5,"PHE A  58;SER A 130;ALA A  46;LEU A  61;ALA A  57","None;SO4 A 304 (-4.1A);None;None;None","1.48A","5oy0b-5hk2A:undetectable","5oy0b-5hk2A:15.81"],["5X1B_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 3","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",3,"ARG A  66;PHE A  58;LEU A  79","None","0.86A","5x1bC-5hk2A:undetectable","5x1bC-5hk2A:19.70"],["6DJZ_A_GMJA301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",6,"ILE A 124;PHE A 133;VAL A 152;HIS A 154;THR A 160;ALA A  86","61V A 301 ( 4.7A);None;None;61V A 301 ( 4.1A);None;None","1.00A","6djzA-5hk2A:34.9","6djzA-5hk2A:100.00"],["6DJZ_A_GMJA301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",9,"MET A  93;LEU A 105;PHE A 133;VAL A 152;HIS A 154;THR A 160;VAL A 162;LEU A 186;ALA A 185","61V A 301 (-3.4A);None;None;None;61V A 301 ( 4.1A);None;None;None;61V A 301 ( 4.2A)","1.49A","6djzA-5hk2A:34.9","6djzA-5hk2A:100.00"],["6DJZ_A_GMJA301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",12,"MET A  93;TYR A 103;LEU A 105;ILE A 124;PHE A 133;VAL A 152;HIS A 154;THR A 160;VAL A 162;LEU A 182;ALA A 185;TYR A 206","61V A 301 (-3.4A);61V A 301 ( 4.3A);None;61V A 301 ( 4.7A);None;None;61V A 301 ( 4.1A);None;None;None;61V A 301 ( 4.2A);61V A 301 (-3.6A)","0.58A","6djzA-5hk2A:34.9","6djzA-5hk2A:100.00"],["6DJZ_A_GMJA301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",6,"PHE A 133;VAL A 152;HIS A 154;THR A 160;LEU A 186;ALA A  86","None;None;61V A 301 ( 4.1A);None;None;None","0.95A","6djzA-5hk2A:34.9","6djzA-5hk2A:100.00"],["6DJZ_A_GMJA301_1","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",6,"SER A 117;TYR A 120;ASP A 126;GLN A 135;GLU A 172;THR A 181","61V A 301 (-2.9A);None;61V A 301 (-3.2A);None;61V A 301 (-2.9A);61V A 301 ( 4.7A)","0.56A","6djzA-5hk2A:34.9","6djzA-5hk2A:100.00"],["6DJZ_B_GMJB301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",7,"SER A 117;PHE A 133;HIS A 154;THR A 160;VAL A 162;TRP A 164;LEU A 186","61V A 301 (-2.9A);None;61V A 301 ( 4.1A);None;None;None;None","1.03A","6djzB-5hk2A:35.1","6djzB-5hk2A:100.00"],["6DJZ_B_GMJB301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",12,"TRP A  89;TYR A 103;LEU A 105;SER A 117;ILE A 124;PHE A 133;HIS A 154;THR A 160;VAL A 162;TRP A 164;THR A 181;LEU A 182","None;61V A 301 ( 4.3A);None;61V A 301 (-2.9A);61V A 301 ( 4.7A);None;61V A 301 ( 4.1A);None;None;None;61V A 301 ( 4.7A);None","0.63A","6djzB-5hk2A:35.1","6djzB-5hk2A:100.00"],["6DJZ_B_GMJB301_1","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",4,"ASP A 126;VAL A 152;GLU A 172;ALA A  86","61V A 301 (-3.2A);None;61V A 301 (-2.9A);None","1.20A","6djzB-5hk2A:35.1","6djzB-5hk2A:100.00"],["6DJZ_B_GMJB301_1","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",6,"TYR A 120;ASP A 126;GLN A 135;VAL A 152;GLU A 172;ALA A 185","None;61V A 301 (-3.2A);None;None;61V A 301 (-2.9A);61V A 301 ( 4.2A)","0.36A","6djzB-5hk2A:35.1","6djzB-5hk2A:100.00"],["6DJZ_C_GMJC301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",9,"ALA A  98;SER A 117;PHE A 133;VAL A 152;HIS A 154;VAL A 162;THR A 181;LEU A 182;TYR A 206","61V A 301 ( 4.8A);61V A 301 (-2.9A);None;None;61V A 301 ( 4.1A);None;61V A 301 ( 4.7A);None;61V A 301 (-3.6A)","0.84A","6djzC-5hk2A:34.1","6djzC-5hk2A:100.00"],["6DJZ_C_GMJC301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",11,"MET A  93;ALA A  98;LEU A 105;SER A 117;PHE A 133;VAL A 152;HIS A 154;VAL A 162;THR A 181;ALA A 185;TYR A 206","61V A 301 (-3.4A);61V A 301 ( 4.8A);None;61V A 301 (-2.9A);None;None;61V A 301 ( 4.1A);None;61V A 301 ( 4.7A);61V A 301 ( 4.2A);61V A 301 (-3.6A)","0.51A","6djzC-5hk2A:34.1","6djzC-5hk2A:100.00"],["6DJZ_C_GMJC301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",9,"MET A  93;ALA A  98;LEU A 105;SER A 117;VAL A 153;HIS A 154;THR A 181;ALA A 185;TYR A 206","61V A 301 (-3.4A);61V A 301 ( 4.8A);None;61V A 301 (-2.9A);None;61V A 301 ( 4.1A);61V A 301 ( 4.7A);61V A 301 ( 4.2A);61V A 301 (-3.6A)","1.45A","6djzC-5hk2A:34.1","6djzC-5hk2A:100.00"],["6DJZ_C_GMJC301_1","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",6,"TRP A  89;LEU A  95;TYR A 120;ASP A 126;GLN A 135;GLU A 172","None;None;None;61V A 301 (-3.2A);None;61V A 301 (-2.9A)","0.34A","6djzC-5hk2A:34.1","6djzC-5hk2A:100.00"],["6DK1_A_GM4A301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",9,"VAL A  84;ALA A  86;TRP A  89;MET A  93;TYR A 103;LEU A 105;TRP A 164;GLU A 172;ALA A 185","61V A 301 (-4.5A);None;None;61V A 301 (-3.4A);61V A 301 ( 4.3A);None;None;61V A 301 (-2.9A);61V A 301 ( 4.2A)","0.74A","6dk1A-5hk2A:34.1","6dk1A-5hk2A:100.00"],["6DK1_A_GM4A301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",10,"VAL A  84;ALA A  86;TRP A  89;MET A  93;TYR A 103;LEU A 105;TYR A 120;ASP A 126;TRP A 164;GLU A 172","61V A 301 (-4.5A);None;None;61V A 301 (-3.4A);61V A 301 ( 4.3A);None;None;61V A 301 (-3.2A);None;61V A 301 (-2.9A)","0.64A","6dk1A-5hk2A:34.1","6dk1A-5hk2A:100.00"],["6DK1_A_GM4A301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",5,"VAL A  84;LEU A 105;ASP A 126;GLU A 172;ALA A  86","61V A 301 (-4.5A);None;61V A 301 (-3.2A);61V A 301 (-2.9A);None","1.49A","6dk1A-5hk2A:34.1","6dk1A-5hk2A:100.00"],["6DK1_B_GM4B301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",11,"VAL A  84;ALA A  86;TRP A  89;TYR A 103;LEU A 105;TYR A 120;ASP A 126;TRP A 164;GLU A 172;ALA A 185;LEU A 186","61V A 301 (-4.5A);None;None;61V A 301 ( 4.3A);None;None;61V A 301 (-3.2A);None;61V A 301 (-2.9A);61V A 301 ( 4.2A);None","0.54A","6dk1B-5hk2A:33.6","6dk1B-5hk2A:100.00"],["6DK1_C_GM4C301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",11,"VAL A  84;ALA A  86;TRP A  89;TYR A 103;LEU A 105;TYR A 120;ASP A 126;TRP A 164;GLU A 172;THR A 181;ALA A 185","61V A 301 (-4.5A);None;None;61V A 301 ( 4.3A);None;None;61V A 301 (-3.2A);None;61V A 301 (-2.9A);61V A 301 ( 4.7A);61V A 301 ( 4.2A)","0.70A","6dk1C-5hk2A:33.7","6dk1C-5hk2A:100.00"],["6DK1_C_GM4C301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","5hk2","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","Homo sapiens",5,"VAL A  84;LEU A 105;ASP A 126;GLU A 172;ALA A  86","61V A 301 (-4.5A);None;61V A 301 (-3.2A);61V A 301 (-2.9A);None","1.44A","6dk1C-5hk2A:33.7","6dk1C-5hk2A:100.00"]]